Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial

Authors

  • Sarah Glewis Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
  • Marliese Alexander Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
  • Senthil Lingaratnam Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia
  • Benjamin Lee Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia
  • Ian Campbell Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
  • Mei Krishnasamy Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Academic Nursing Unit, Peter MacCallum Cancer Centre, Melbourne, Australia; VCCC Alliance, Parkville, Australia
  • Maarten IJzerman Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Cancer Research, University of Melbourne, Parkville, Australia; Melbourne School of Population and Global Health, Centre for Health Policy, University of Melbourne, Parkville, Australia
  • Mussab Fagery Cancer Research, University of Melbourne, Parkville, Australia
  • Sam Harris Department of Medical Oncology, Bendigo Health, Bendigo, Australia
  • Chloe Georgiou Department of Medical Oncology, Bendigo Health, Bendigo, Australia
  • Craig Underhill VCCC Alliance, Parkville, Australia; Border Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre, East Albury, Australia; UNSW Rural Medical School, East Albury, Australia
  • Mark Warren Department of Medical Oncology, Bendigo Health, Bendigo, Australia
  • Robert Campbell Department of Medical Oncology, Bendigo Health, Bendigo, Australia
  • Jennifer Martin School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
  • Jeanne Tie Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
  • Michael Michael Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

DOI:

https://doi.org/10.1080/0284186X.2022.2109423

Abstract

No abstracts available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2022-09-02

How to Cite

Glewis, S., Alexander, M., Lingaratnam, S., Lee, B., Campbell, I., Krishnasamy, M., … Michael, M. (2022). Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial. Acta Oncologica, 61(9), 1136–1139. https://doi.org/10.1080/0284186X.2022.2109423

Issue

Vol. 61 No. 9 (2022): Acta Oncologica

Section

Articles